药明生物:2025H1业绩表现亮眼 持续深化全球产能布局

开源证券
Aug 25

2025H1 业绩稳健增长,上调全年收入指引2025H1 公司实现营收99.53 亿元,同比增长16.08%;归母净利润23.39 亿元,同比增长56.05%;经调整纯利28.40 亿元,同比增长11.60%;毛利率约42.73%,同比提升约3.6pct。2025H1 营收端稳健增长,盈利能力快速提升,公司上调2025全年营收指引至14%-16%;截至2025 年6 月底,公司未完成订单总量约...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10